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ABSTRACT
 
Background
 
Alcohol is one of  the most important risk factors for burden of  disease. 
 
Objective
 
To estimate the
number of  deaths and the years of  life lost attributable to alcohol for Canada 2001 using different ways to measure
alcohol exposure. 
 
Methods
 
Distribution of  exposure was taken from a major national survey of  Canada, the Cana-
dian Addiction Survey, and corrected for per capita consumption from production and sales. For chronic disease, risk
relations were taken from the published literature and combined with exposure to calculate age- and sex-specific
alcohol-attributable fractions (AAFs). For injury, AAFs were taken directly from available statistics. Information on
mortality, with cause of  death coded according to the International Classification of  Diseases version 10 (ICD-10) was
obtained from Statistics Canada. 
 
Results
 
For Canada in 2001, 4010 of  all deaths in the group below 70 years of  age
were attributable to alcohol, 3132 in men and 877 in women. This constituted 6.0% of  all deaths in Canada in this age
group, 7.6% for men, and 3.5% for women. The 4010 deaths are a net figure, already taking into account the deaths
prevented by moderate consumption of  alcohol. Main causes of  alcohol-attributable death were unintentional injuries,
malignant neoplasms and digestive diseases. Ischaemic heart disease (IHD) was the biggest cause of  death prevented by
alcohol, with 78.7% of  all alcohol-attributable prevented deaths in the age groups of  70 years and above. A total of
144 143 years of  life were lost prematurely in Canada in that year, 113 079 years in men and 31 063 years in women.
 
Discussion
 
Regardless of  the assumptions made, alcohol is a major contributor to mortality in Canada. The impact of
alcohol on social life is not confined to mortality, as other studies indicated that alcohol is linked even more strongly to
disability and social harm. Alcohol-attributable harm could be substantially reduced, however, if  known effective pol-
icies were introduced.
 
Keywords
 
Alcohol-attributable fraction (AAF), alcohol consumption, Canada, mortality, potential years of  life lost
(PYLL), relative risk (RR).
 
INTRODUCTION
 
Alcohol is accountable for high levels of  mortality, mor-
bidity and social problems. More than 60 causes of  death
have been attributed to alcohol consumption (Schultz
 
et al
 
. 1991; Corrao 
 
et al
 
. 1999; Rehm 
 
et al
 
. 2003a,b).
Results from studies investigating deaths attributable to
alcohol vary by country and methodology (e.g. Schultz
 
et al
 
. 1990; English 
 
et al
 
. 1995; Single 
 
et al
 
. 2000; Britton
 
et al
 
. 2003; Centers for Disease Control & Prevention
2004; White 
 
et al
 
. 2004).
From a public health perspective, alcohol consump-
tion has been shown to have adverse consequences, such
as various cancers, hypertension, cirrhosis of  the liver,
pancreatitis, alcohol dependence, accidents and violence
(English 
 
et al
 
. 1995; Rehm 
 
et al
 
. 2003a, 2004). On the
other hand, when consumed in moderation, there was
evidence of  a decreased risk of  ischaemic heart disease
(IHD) (Doll 
 
et al
 
. 1994; Klatsky 1994; Chick 1998; Pud-
dey 
 
et al
 
. 1999; Rehm 
 
et al
 
. 2003c). In addition, accord-
ing to current epidemiological standards, there has been
some evidence of  a protective effect of  moderate consump-
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tion on ischaemic stroke, diabetes, cholethiasis or gall-
stones (Ashley 
 
et al
 
. 2000). For other conditions such as
peripheral vascular disease, cognitive functioning (Eck-
ardt 
 
et al
 
. 1998; Chick 1999), stress reduction (Baum-
Baicker 1985; Hauge & Irgens-Jensen 1990), mood eleva-
tion (Pohorecky 1991; Castaneda 
 
et al
 
. 1996, 1998) and
other subjective psychosocial effects, the evidence was
neither consistent nor conclusive (Ashley 
 
et al
 
. 2000).
All-cause mortality as a summary measure thus has a
 
J
 
-shaped relationship with alcohol consumption, at least
for people older than 40 years of  age, when the main pro-
tective effects of  alcohol on IHD become evident (English
 
et al
 
. 1995; Rehm & Bondy 1998; Rehm 
 
et al
 
. 2001a;
Gmel 
 
et al
 
. 2003a; White 
 
et al
 
. 2004). This 
 
J
 
-shaped rela-
tionship indicates that low to moderate drinkers have a
lower mortality risk compared to the abstainers, whereas
the mortality risk for highest level drinkers is higher than
that of  both moderate drinkers and abstainers.
The exact shape of  the curve depends on the underly-
ing mix of  causes of  death and the patterns of  drinking
(Rehm 
 
et al
 
. 2004). Thus, the relationship between con-
sumption and all-cause mortality cannot be used to
derive precise estimates of  alcohol-attributable mortality.
Instead a disease-specific approach is necessary. The cur-
rent paper uses such a disease-specific approach to esti-
mate the number of  deaths and potential years of  life lost
for Canada in 2001.
 
METHODS
 
The aim of  the present study was to estimate the propor-
tion of  deaths ‘caused’ or ‘prevented’ by alcohol and
premature deaths in Canada for the year 2001. In the
following paragraphs, three elements necessary for this
estimate are described: measurement of  exposure, deter-
mination of  risk relationships and attributable fractions
and outcome information.
 
Prevalence of  alcohol consumption in Canada
 
To measure alcohol consumption, we followed the
approach of  English 
 
et al
 
. (1995) and used four drinking
categories based on average volume of  alcohol consumed
(see Table 1 for definition). These specific drinking cate-
gories have been used, because most meta-analyses give
results based on these categories (see Rehm 
 
et al
 
. 2003a;
for an overview of  meta-analyses).
The prevalence data of  different levels of  current alco-
hol consumption were collected between 2003 and 2004
through the Canadian Addiction Survey (CAS) (Cana-
dian Centre on Substance Abuse 2004). This survey was
selected because it collected good alcohol consumption
exposure data which are temporally closest to the mor-
tality data. As alcohol consumption has been relatively
stable in Canada over the past years, the difference of  2–
 
Table 1
 
Prevalence of  alcohol consumption in Canada 2003/2004† according to age, sex and drinking category.
 
Drinking categories
Overall
(all ages) 15–29 years 30–44 years 45–59 years 60–69 years 70–79 years 80
 
+
 
 
 
years
 
Abstention and very light drinking*
Female 66.9 59.0 62.1 65.3 68.4 70.5 72.6
Male 40.4 30.2 35.1 40.0 45.0 48.3 51.5
Drinking category I*
Female 24.9 34.8 31.0 27.1 23.2 20.7 18.1
Male 46.8 51.6 48.6 45.5 42.4 40.4 38.3
Drinking category II*
Female 6.3 3.2 4.3 5.5 6.6 7.4 8.2
Male 6.5 8.7 8.2 7.6 7.1 6.7 6.4
Drinking category III*
Female 1.9 3.0 2.6 2.2 1.8 1.5 1.1
Male 6.3 9.4 8.1 6.8 5.5 4.6 3.8
Total 100 100 100 100 100 100 100
 
Drinking categories Females Males
 
Abstainer or very light drinker 0–
 
<
 
 0.25 g/day 0–
 
<
 
 0.25 g/day
Drinking category I 0.25–
 
<
 
 20 g/day 0.25–
 
<
 
 40 g/day
Drinking category II 20–
 
<
 
 40 g/day 40–
 
<
 
 60 g/day
Drinking category III 40
 
+
 
 g/day 60
 
+
 
 g/day
 
†
 
Average volume of  alcohol consumption has been based on a smoothed quantity frequency measure derived from the Canadian Addiction Survey, cor-
rected for per capita consumption. For further explanations of  this measure please see text. *The drinking categories were based on the following defi-
nitions (see National Health and Medical Research Council, Australia 1992; English 
 
et al
 
. 1995)
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3 years between mortality and exposure data seems to be
negligible.
The CAS was based on a regionally stratified two-stage
(telephone household, respondent) random sample. The
survey used random-digit-dialling methods via computer
assisted telephone interviewing. The sampling frame was
based on an electronic inventory (Statplus) of  all active
telephone area codes and exchanges in Canada. Within
selected households, one respondent aged 15 years or
older who could complete the interview in English or
French was selected according to the most recent birth-
day of  household members. The selected individuals were
interviewed by professional interviewers using a struc-
tured questionnaire. The sample was drawn randomly
from the whole of  Canada taking into consideration age,
sex and region to avoid sample bias. This survey had a
sample size of  13 909 men and women, and a 47%
response rate for individuals. It was decided to use this
survey despite the relatively low response rate because it
had the necessary exposure measures for the intended
calculations, large sample size to allow provincial calcu-
lations and closest temporal proximity to the mortality
data. In addition, it has been shown that higher response
rates in surveys did not essentially change the results
with respect to the distribution of  alcohol consumption
(Gmel & Rehm 2004). To strengthen the confidence in
these data and to ensure that characteristics of  CAS sam-
ple are similar to the Canadian population, this sample
was weighted to correspond to the age and sex distribu-
tion of  the Canadian population.
Different measures for alcohol exposure were used,
including a quantity frequency (QF) measure, where
usual frequency and usual quantity per drinking occa-
sion were asked in separate questions and then combined
to derive overall volume. A 7-day protocol was also used
where, starting with the day before the survey, consump-
tion of  each of  the past 7 days was asked (for further
explanation see Gmel & Rehm 2004). As QF is a more reli-
able measure to indicate individual volume (Gmel &
Rehm 2004), we used this measure for our main sce-
nario, and the 7-day protocol as one of  the sensitivity
analyses. Sensitivity analyses were conducted as it has
been shown clearly that method of  assessment has an
important impact on estimated alcohol-attributable mor-
tality and other harm (Rehm 
 
et al
 
. 1999).
For per capita consumption (for a definition see Rehm
 
et al
 
. 2003d), numbers were taken from the Global Alco-
hol Database (http://www3.who.int/whosis). As the
CAS accounted for only 30% and 40% of  the per capita
consumption (including unrecorded consumption),
depending on which measure was used, we scaled the
two highest alcohol consumption categories of  the QF
upwards in our main scenario by the factor of  under-
reporting for QF. In other words, we multiplied the age
and sex-specific prevalence rates by 2.7 to reflect the
true per capita consumption based on the coverage rate
of  36.6% or the QF. Per capita consumption, when
including unrecorded consumption, is usually consid-
ered as the best measure for overall consumption in a
country (Gmel & Rehm 2004). Of  course, this measure
has the disadvantage that it cannot give any indication
of  sex- or age-distributions of  drinking (Rehm 
 
et al
 
.
2003d).
 
Computing alcohol-attributable deaths
 
The alcohol-attributable fraction (AAF) is generally
defined as the proportion of  the disease in the population
that will disappear if  alcohol is removed (Walter 1976,
1980). Since alcohol may ‘cause’ or ‘prevent’ deaths, the
AAF can be positive or negative. AAFs were assessed for
different specific causes of  natural and unnatural deaths
by two methods:
• AAFs for chronic disease were calculated by combining
exposure and relative risk estimates from meta-analy-
ses. Relative risk here denotes the ratio of  the probabil-
ity of  developing, in a specified period of  time, a disease
among those exposed to alcohol, compared with the
probability of  developing this disease for abstainers.
• AAFs for injuries were based on direct estimates of  alco-
hol involvement where available for Canada (traffic
accidents; fire); and for other types of  injury were based
on results from the America A region derived by the
comparative risk analysis of  the Global Burden of  Dis-
ease study (Rehm 
 
et al
 
. 2004; for details of  calculation
see below).
For chronic disease conditions, the AAFs were calcu-
lated from alcohol exposure prevalence proportions in
Canada and the pooled relative risks for the diseases from
the update of  comprehensive meta-analyses. We used the
most comprehensive meta-analysis for each condition,
as indicated in Table 2 (see Rehm 
 
et al
 
. 2003a for an
overview). ‘Most comprehensive’ was determined by the
meta-analysis with the greatest number of  unique studies
included. Other selection criteria included whether the
methodologies were comparable and fulfilled the follow-
ing standards: clear and explicit criteria for selection of
studies, outcome exactly defined as needed for our study,
control for and reporting of  heterogeneity, exposure
defined in terms of  average volume of  drinking and exclu-
sion of  studies not based on general population. As many
of  the meta-analyses were based on prior meta-analyses
for the same disease conditions and had merely added the
newly published literature, this identification was often
easy (e.g. Gutjahr 
 
et al
 
. 2001 where most of  the analy-
ses were based on the previous works of  English 
 
et al
 
.
1995 and Single 
 
et al
 
. 1996). Where meta-analyses
used other drinking categories than the ones used here,
we interpolated the respective regression coefficients
 © 2006 The Authors. Journal compilation © 2006 Society for the Study of  Addiction
 
Addiction, 
 
101
 
, 373–384
 
376
 
Jürgen Rehm 
 
et al.
 
Table 2
 
Alcohol-related disease categories and sources for determining risk relations including alcohol-attributable fractions
(AAFs).
 
Condition ICD-10 code Source for meta-analysis or AAF
 
Malignant neoplasms
Mouth and oropharynx cancers C00–C14 Gutjahr 
 
et al
 
. (2001)
Oesophageal cancer C15 Gutjahr 
 
et al
 
. (2001)
Liver cancer C22 Gutjahr 
 
et al
 
. (2001)
Laryngeal cancer C32 Gutjahr 
 
et al
 
. (2001)
Breast cancer C50 Ridolfo & Stevenson (2001)
Other neoplasms D00-D48 Rehm 
 
et al
 
. (2004)
Diabetes
Diabetes mellitus E10–E14 Gutjahr 
 
et al
 
. (2001)
Neuro-psychiatric conditions
Alcoholic psychoses F10.0, F10.3–F10.9 100% AAF per definition
Alcohol abuse F10.1 100% AAF per definition
Alcohol dependence syndrome F10.2 100% AAF per definition
Unipolar major depression F32–F33 Rehm 
 
et al
 
. (2004)
Degeneration of  nervous system due to G31.2 100% AAF per definition
alcohol
Epilepsy G40–G41 Gutjahr 
 
et al
 
. (2001)
Alcoholic polyneuropathy G62.1 100% AAF per definition
Cardiovascular diseases
Hypertensive disease I10–I15 Corrao 
 
et al
 
. (1999)
Ischaemic heart disease I20–I25 Corrao 
 
et al
 
. (2000); Rehm 
 
et al
 
. (2004)
Alcoholic cardiomyopathy I42.6 100% AAF per definition
Cardiac arrhythmias I47–I49 Gutjahr 
 
et al
 
. (2001)
Heart failure and ill-defined
complications of  heart disease
I50–I52, I23, I25.0, 
I97.0, I97.1, I98.1
This is an unspecific category with no
identification of  underlying pathology.
Therefore, the relationship between average
volume of  consumption cannot be
determined by usual meta-analysis
Cerebrovascular disease I60–I69
Ischaemic stroke I60–I62 Reynolds 
 
et al
 
. (2003)
Haemorrhagic stroke I63–I66 Reynolds 
 
et al
 
. (2003)
Oesophageal varices I85 Gutjahr 
 
et al
 
. (2001)
Digestive diseases
Alcoholic gastritis K29.2 100% AAF per definition
Cirrhosis of  the liver K70, K74 Rehm 
 
et al
 
. (2004)
Cholelithiasis K80 Gutjahr 
 
et al
 
. (2001)
Acute and chronic pancreatitis K85, K86.1 Corrao 
 
et al
 
. (1999)
Chronic pancreatitis (alcohol-induced) K86.0 100% AAF per definition
Skin diseases
Psoriasis L40 Gutjahr 
 
et al
 
. (2001)
Conditions arising during the perinatal period
Low birth weight: as defined by the P05–P07 Gutjahr 
 
et al
 
. (2001)
global burden of  disease study*
Fetal alcohol syndrome (dysmorphic) Q86.0 100% AAF per definition
Excess alcohol blood level R78.0 100% AAF per definition
Unintentional injuries
Motor vehicle accidents § (see footnote) Traffic Injury Research Foundation of  Canada 2004;
Transport Canada (2004)
Poisonings X40–X49 Rehm 
 
et al
 
. (2004); adjusted to Canada by AAF for 
traffic accidents
Falls W00–W19 Rehm 
 
et al
 
. (2004); adjusted to Canada by AAF for 
traffic accidents
Fires X00–X09 Council of  Canadian Fire Marshals and Fire 
Commissioners (2003)
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to the midpoints of  our drinking categories (for defini-
tion of  drinking categories see Table 1).
The relative risk for each condition was combined
with different levels of  alcohol consumption for each sex
and age group and an attributable fraction was obtained
using the following formula (see Walter 1976, 1980),
which uses no consumption at all as counterfactual sce-
nario (see Rehm 
 
et al
 
. 2001b; Murray 
 
et al
 
. 2003; for a
discussion of  this choice).
 
AAF
 
 
 
=
 
 [
 
Σ
 
k
i
 
=
 
1
 
 
 
P
 
i
 
(
 
RR
 
i
 
  
 
−
 
  1)]/[
 
Σ
 
k
i
 
=
 
0
 
 
 
P
 
i
 
(
 
RR
 
i
 
 
 
−
 
 1) 
 
+
 
 1]
where 
 
i
 
: exposure category with baseline exposure or no
alcohol 
 
i
 
 
 
=
 
 0; 
 
RR
 
i
 
: relative risk at exposure level 
 
i
 
 com-
pared to no consumption; 
 
P
 
i
 
: prevalence of  the i
 
th
 
 cate-
gory of  exposure.
The AAFs were then applied to the mortality data to
estimate the number of  alcohol attributed deaths by age
and sex.
For injuries, a different approach had to be adopted
because injuries are usually more determined by patterns
of  excessive per occasion drinking than by average
volume of  alcohol consumption (see Rehm 
 
et al
 
. 2003a,
2004). Thus we looked for injury statistics that would
include the blood alcohol level in the event. This was
available for the traffic sector, where statistics exist in
Canada to explicitly account for blood alcohol concentra-
tion (BAC; Traffic Injury Research Foundation of  Canada
2004; Transport Canada 2004). To determine causality
of  alcohol, we used the criterion of  BAC larger than
100 mg/dl (see also Smith 
 
et al
 
. 1999). This does exclude
all injury with involvement of  alcohol at lower levels of
BAC. As alcohol influences psychomotor ability at much
lower levels (Eckardt 
 
et al
 
. 1998), the criterion can be
seen as conservative.
For injury categories, where we had no Canadian
studies (e.g. falls), we based AAFs on the age and sex-
specific values of  the America A region of  the Compara-
tive Risk Analysis (CRA) of  the Global Burden of  Disease
study (Rehm 
 
et al
 
. 2004). The CRA America A region
consisted of  population weighted estimates for Canada,
Cuba and the United States combined, which were
heavily based on US studies (especially Smith 
 
et al
 
. 1999).
These estimates were scaled differences between CRA
and Canadian data for motor vehicle accidents: if, for
example, the Canadian prevalence rates were 8% lower
for motor vehicle accidents in a sex–age category, this
ratio (0.92) was transferred to decrease the AAF for
other injury types without specific Canadian data; if  they
 
Accidental poisoning and exposure to X45 100% AAF per definition
alcohol
Drowning W65-W74 Rehm 
 
et al
 
. (2004); adjusted to Canada by AAF for 
traffic accidents
Other unintentional injuries †Rest of  V & W20–W64,
W75–W99, X10–X39,
X50–X59, Y40–Y86,
Y88, Y89
Rehm 
 
et al
 
. (2004); adjusted to Canada by AAF for 
traffic accidents
Intentional injuries
Self-inflicted injuries X60–X84, Y87.0 Rehm 
 
et al
 
. (2004); adjusted to Canada by AAF for 
traffic accidents
Intentional self-poisoning by and X65 100% AAF per definition
exposure to alcohol
Homicide X85–Y09, Y87.1 Rehm 
 
et al
 
. (2004); adjusted to Canada by AAF for 
traffic accidents
Other intentional injuries Y35 Rehm 
 
et al
 
. (2004); adjusted to Canada by AAF for 
traffic accidents
Ethanol and methanol toxicity, undetermined 
intent
Y15 100% AAF per definition
 
Condition ICD-10 code Source for meta-analysis or AAF
 
Table 2
 
Cont.
 
*Relative risk refers to drinking of  mothers. §V021–V029, V031–V039, V041–V049, V092, V093, V123–V129, V133–V139, 
V143–V149, V194–V196, V203–V209, V213–V219, V223–V229, V233–V239, V243–V249,V253–V259, V263–V269, V273–
V279, V283–V289, V294–V299, V304–V309, V314–V319, V324–V329, V334–V339, V344–V349, V354–V359, V364–V369, 
V374–V379, V384–V389, V394–V399, V404–V409, V414–V419, V424–V429, V434–V439, V444–V449, V454–V459, V464–
V469, V474–V479, V484–V489, V494–V499, V504–V509, V514–V519, V524–V529, V534–V539, V544–V549, V554–V559, 
V564–V569, V574–V579, V584–V589, V594–V599, V604–V609, V614–V619, V624–V629, V634–V639, V644–V649, V654–
V659, V664–V669, V674–V679, V684–V689, V694–V699, V704–V709, V714–V719, V724–V729, V734–V739, V744–V749, 
V754–V759, V764–V769, V774–V779, V784–V789, V794–V799, V803–V805, V811, V821, V830–V833, V840–V843, V850–
V853, V860–V863, V870–V878, V892. 
 
†
 
Rest of  V 
 
=
 
 V-series MINUS §.
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were higher, the AAFs for other injury types were
increased accordingly.
 
Mortality data
 
Mortality data in Canada for the year 2001, with the
underlying cause coded according to the International
Classification of  Diseases version 10 (ICD-10), were
obtained from Statistics Canada. Table 2 gives an over-
view of  the disease conditions extracted by sex and age
groups; 2001 was selected because it was the last year
available.
 
Potential years of  life lost
 
Potential years of  life lost (PYLL) is an indicator of  pre-
mature mortality. People dying due to alcohol consump-
tion would have lived longer if  they had not drunk
alcohol. The average extra time such individuals would
have lived is known as the residual life expectancy. For
example, if  a male died of  alcoholic liver cirrhosis at age
50, in Canada he would have a residual life expectancy
of  28.4 years (WHO Statistical Information System
2000). The sum of  these extra times for all people dying
from alcohol consumption is known as PYLL due to alco-
hol. PYLL for each sex–age group category can be esti-
mated from the observed mean age at death in the age
interval and the standard life expectancies tables at the
exact ages defining the age interval through interpola-
tion. The standard life expectancies table for Canada
mortality in 2000 is available from the World Health
Organization (WHO) website (http://www.who.int/
evidence). In calculating the mean ages within the inter-
vals, the rules specified by the Global Burden of  Disease
study have been followed (Mathers 
 
et al
 
. 2001). PYLL
due to death in Canada has been calculated for each age
group (0–14, 15–29, 30–44, 45–59, 60–69, 70–79 and
80 
 
+
 
 years) by multiplying the number of  deaths by the
interpolated life expectancy for the observed mean age at
death in the interval. Mean age for the 80 
 
+
 
 age groups
for men (84 years) and women (85 years) were calcu-
lated from the life expectancy table. The upper age limit
of  76.0 years for males and 81.5 years for females was
used to approximate the life expectancy of  Canadians for
both sexes at birth. PYLL were calculated per population
of  100 000.
 
Sensitivity analyses
 
Different measures of  alcohol exposure were used as a
basis to estimate alcohol-attributable mortality and PYLL:
• the 7-day-consumption protocol;
• the usual QF measure, as indicated by the respondents;
• a smoothed QF, where abrupt changes in prevalence
of  different drinking level categories between adja-
cent age groups were smoothed on the basis of  the
overall linear age distribution of  volume of  drinking;
and
• a smoothed QF adjusted in a way that the overall vol-
ume in Canada corresponded to the per capita con-
sumption, including unrecorded consumption.
As the last measure corresponded to the best estimate
of  overall consumption in Canada, it was considered the
main measure of  alcohol exposure.
 
RESULTS
 
Table 1 gives an overview of  the estimated volume of
alcohol exposure in Canada by sex and age group. As
expected, men consumed on average more than women,
and alcohol consumption decreased with age.
Table 3 provides the estimates of  alcohol-attributable
deaths and deaths prevented by alcohol consumption.
Overall, in Canada for 2001, 3892 alcohol-attributable
deaths were estimated accounting for 3313 deaths
among men and 579 among women. Please note that
these numbers were derived by multiplying AAFs with
number of  deaths for each category, thereby producing
numbers with decimals. As a result, there may be
rounding errors after collapsing numbers over different
categories.
The 3892 alcohol-attributable deaths constituted
1.8% of  all Canadian deaths. These were net figures,
i.e. they included estimates of  deaths prevented by
alcohol. Overall, there were 7597 deaths attributable
to alcohol and 3705 deaths prevented by alcohol, cal-
culated using the same epidemiological procedure
described above. Most of  the estimated deaths pre-
vented by alcohol were from IHD (3010 deaths). Over-
all, most of  these statistically calculated ‘prevented’
deaths occur after age 70 (78.7% of  all prevented
deaths). There is some doubt as to whether the meta-
analytically derived AAFs both for deaths caused and
for preventive deaths really apply to this age group, as
relative risks tend to converge to 1 with age. Thus, we
additionally present the figures of  alcohol-attributable
mortality for the age-group under 70 years. In this age
group, 4010 of  all deaths in Canada 2001 were attrib-
uted to alcohol, accounting for 3132 men and 877
women. This represented 6.0% of  all Canadian deaths
in this age-group.
Among deaths caused by alcohol, the three biggest
contributors were unintentional injuries, malignant neo-
plasms and digestive diseases (see Table 3). With respect
to single disease categories, cirrhosis of  the liver (1203
deaths, 854 males; 349 females), motor vehicle accidents
(801 deaths, 662 males; 138 females), suicides/self-
inflicted injuries (619 deaths, 507 males; 113 females),
oesophageal cancer (467 deaths, 383 males; 84 females)
and cardiac arrhythmias (412 deaths, 218 males; 194
 Alcohol and mortality in Canada 2001 379
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females) constituted the largest alcohol-attributable
categories.
Overall, alcohol affected more men than women: in
men 3.0% of  the deaths were alcohol-attributable and in
women the figure was 0.5% (in the age group under 70:
7.6% in men; 3.5% in women).
With respect to age, the overall average age for an
alcohol-attributable death was 45.9 years for men and
58.8 years for women. There were notable differences
between disease categories. For cardiac arrhythmias,
the average age for an alcohol-attributable death was
74.8 years for men and 81.1 years for women. Alcohol-
attributable deaths due to motor vehicle accidents
occurred at the average age of  33.9 years for men and
41.3 years for women. For the category of  alcohol-
prevented deaths in general, the mean age was
74.4 years among men and 80.7 years among women.
In 2001, the PYLL rate for Canada for deaths due to
alcohol was 769 per 100 000 for men and 203 per
100 000 for women aged 0–80 + (Table 4). That is, for
every 100 000 people in the population, there was a
potential loss of  769 years of  life among men and
203 years of  life among women as a result of  premature
death due to alcohol. A high PYLL rate for men was
observed, indicating higher levels of  premature mortality
among men compared to women.
Although the estimates of  alcohol exposure varied
widely, i.e. by a factor of  three between some survey mea-
sures and per capita consumption, the estimates for
alcohol-attributable mortality did not vary by such a
large degree (see Table 5): the lowest estimate was only
22.8% lower than the highest estimate.
Similarly, the PYLL rate per 100 000 population var-
ied much less compared to the variation in exposure. For
instance, between the main scenario (see Table 4) and a
scenario based on usual quantity–frequency, the differ-
ences were as follows: the rate of  alcohol-attributable
years of  life lost per 100 000 men decreased from 769 to
698 (−9.2%) and the respective rate for women decreased
from 203 to 174 (−14.3%; details of  the calculation avail-
able from the authors).
There are three main reasons for the relatively small
variation in overall deaths or PYLL. First, only part of  the
alcohol-attributable mortality was based on survey esti-
mates (see Methods above). The rest was derived using
direct estimation from statistics. Secondly, as alcohol has
protective as well as detrimental effects, and as the esti-
Table 5 Sensitivity analysis on resulting burden under different exposure scenarios.
Exposure 
scenarios Gender
Malignant
neoplasms Diabetes
Neuro-
psychiatric
conditions
Cardiovascular
diseases
Digestive
diseases
Skin
diseases
Conditions 
arising during
perinatal period
Total 
net
deaths†
S1 usual QF Male 828 −68 592 −1533 580 1 4 2709
Female 389 −61 182 −860 209 0 2 551
S2 7-day-recall Male 727 −47 583 −1293 469 1 4 2750
Female 365 −56 181 −797 182 0 2 568
S3 smoothed 
usual QF
Male 865 −70 596 −1583 591 1 4 2710
Female 426 −71 185 −1149 210 0 2 293
S4 smoothed 
adjusted QF
Male 1148 −167 620 −1510 906 2 9 3313
Female 628 −90 199 −1218 364 0 5 579
†Note that the total of  net deaths is not the sum of  the chronic conditions only, but the sum of  these conditions plus the deaths due to injury (see Table 3
for numbers). As the latter were estimated directly from statistics and independently of  exposure, they remain constant for all scenarios. S1 = Alcohol-
attributable fractions (AAF) based on usual quantity frequency (QF) measure. S2 = AAF based on 7-day-recall. S3 = AAF based on smoothed usual QF
measure. S4 = AAF based on smoothed QF measure adjusted for per capita consumption.
Table 4 Potential years of  life lost (PYLL) attributable to alcohol
in Canada 2001 by age and sex—main scenario.
Gender
Age group
(years)
Alcohol-attributable
death all causes PYLL
Men 0–14 50 3418.1
15–29 724 39 349.4
30–44 844 33 760.0
45–59 1011 26 437.7
60–69 504 8038.8
70–79 268 2559.4
80+ −88 −484.0
113 079.3
Alcohol-attributable years of  life lost per 100 000 men = 769
Women 0–14 24 1770.8
15–29 117 6970.9
30–44 219 9828.7
45–59 348 10 669.7
60–69 169 3337.8
70–79 74 903.5
80+ −372 −2418.0
31 063.4
Alcohol-attributable years of  life lost per 100 000 women = 203
Total PYLL 144 143
© 2006 The Authors. Journal compilation © 2006 Society for the Study of  Addiction Addiction, 101, 373–384
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mation of  these effects depends on certain patterns of
drinking (Rehm et al. 2003a), the effects of  changes in
volume of  alcohol consumption on mortality are not lin-
ear, but depend on the distribution of  drinking with
respect to different volume categories, sex and age.
Thirdly, a number of  disease conditions are wholly attrib-
utable to alcohol (e.g. alcohol dependence), and thus
their mortality is estimated independently of  prevalence
of  alcohol consumption.
DISCUSSION
Alcohol consumption has substantial consequences for
public health. Regardless of  how alcohol intake is mea-
sured, it causes substantial mortality and years of  life lost
in Canada. Before we address potential ways to reduce
alcohol-related harm, we would like to outline some of
the limitations and potential problems of  the present
study. Exposure measurement is one of  the biggest chal-
lenges in alcohol epidemiology. While we have relatively
good per capita estimates (Rehm et al. 2003d), at least in
countries such as Canada with relatively small propor-
tions of  unrecorded consumption, the distribution by sex
and age, as derived from surveys, is problematic. The
main problem is that surveys account for 50% or less of
sales/production  figures.  That  fact  has  been  known
for some time (e.g. Midanik 1988), but has not been
addressed adequately with respect to epidemiology. The
underlying measures of  exposure also explain some of  the
variation between studies, where overall little or no net
loss of  mortality could be measured (e.g. Single et al.
1996; Britton et al. 2003; White et al. 2004) compared to
studies where the net mortality is considerable (such as
Rehm et al. 2004, or the present study). In the studies
with little or no net loss of  mortality, level of  alcohol con-
sumption was derived from surveys resulting in consider-
able underestimation of  true consumption. There are
other differences that explain the variations in study
results, most importantly the number of  disease catego-
ries included and the estimation of  injury deaths (based
on country-specific statistics or not). In comparison with
the earlier Canadian study of  Single and colleagues (Sin-
gle et al. 1996), three other changes are important: the
proportion of  deaths in Canada due to IHD and cere-
brovascular diseases decreased, and the relative risk
estimates for the latter disease category changed
considerably (compare the relative risks provided by
English et al. 1995 to those from Reynolds et al. 2003).
Thus, the estimated overall protective effect of  alcohol
consumption decreased.
A second problem concerns the estimation of  risk rela-
tions for chronic disease, which still mainly do not take
into account patterns of  drinking. This may be less rele-
vant for malignant neoplasm but certainly there is good
evidence on alcohol and IHD to demonstrate that drink-
ing pattern plays a crucial role (Puddey et al. 1999; Rehm
et al. 2003c). There are also good examples of  how this is
relevant for public health. For example, in a representa-
tive follow-up study in the United States, a protective
effect of  average moderate consumption could be found in
whites but not in African Americans (Sempos et al. 2002;
for a Canadian example on the relevance of  patterns see
Murray et al. 2002). Thus, the burden estimates for all
diseases where patterns are important can only be
considered preliminary until we have a better under-
standing of  the patterns of  consumption in a population
and the resulting disease outcomes. This point is espe-
cially important for the area of  cardiovascular disease
outcomes, where patterns of  drinking may change the
result from beneficial to detrimental effects of  alcohol
(Gmel et al. 2003b).
Thirdly, as already indicated above, the age specificity
of  relative risks between exposure and outcomes should
be taken into consideration. For example, the relative risk
of  alcohol for IHD declines with age (Abrams et al. 1995),
but in most estimations of  alcohol-related harm, includ-
ing this paper, the same relative risks have been used for
all age groups. This leads to an overestimation of  deaths
caused and prevented by alcohol in older age groups,
which is especially relevant for IHD deaths prevented,
where we almost certainly obtain a significant overesti-
mate using the current methodology. In fact, the majority
of  the beneficial effects of  alcohol would disappear if  age-
specific relative risk estimates were used.
While such details are certainly important in improv-
ing future estimations of  burden, they should not detract
from the main result in this study. Under all assumptions,
alcohol consumption in Canada resulted in a consider-
able burden of  mortality and disease. In appraising this
burden, it should be mentioned that disease burden is
only part of  the overall alcohol-related burden, and is
actually considerably smaller than social harm in some
regions (Room et al. 2003). Thus, in making policy deci-
sions, consideration should be given to all consequences
of  alcohol, including social harm. In shaping policies, one
must also look at the whole picture of  the alcohol con-
sumption culture and not concentrate only on excessive
drinking (Centers for Disease Control & Prevention
2004), as excessive drinking and moderate drinking,
with their different effects on health, are often inter-
twined, i.e. effects on one style may have unwanted
effects on the other.
The burden related to alcohol in Canada is an unnec-
essary one. A large portion of  this burden could be
reduced considerably in a short period of  time (WHO
2002; Chisholm et al. 2004) if  known effective policies
were implemented. In Canada, policies such as taxation,
improvement of  drinking driving countermeasures and
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specific measures to reduce aggression and violence seem
to be the most promising policies, given the epidemiolog-
ical profile (Babor et al. 2003; Chisholm et al. 2004;
Room et al. 2005). Such policies have proved their effec-
tiveness in many jurisdictions and they could show
effects almost immediately (Babor et al. 2003; Chisholm
et al. 2004; Room et al. 2005).
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